Arjo AB (publ) (FRA:A39)

Market Cap	638.03M -27.3%
Revenue (ttm)	987.44M -4.9%
Net Income	31.99M -23.2%
EPS	0.12 -23.2%
Shares Out	n/a
PE Ratio	19.95
Forward PE	12.15
Dividend	0.09 (3.75%)
Ex-Dividend Date	Apr 23, 2026

Volume	n/a
Average Volume	n/a
Open	2.300
Previous Close	2.354
Day's Range	2.300 - 2.300
52-Week Range	2.220 - 3.236
Beta	n/a
RSI	47.66
Earnings Date	Mar 31, 2026

About Arjo AB

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, hygiene, prevention of pressure injuries and blood clots, and leg ulcer treatment and prevention, as well as for obstetric and cardiac diagnostics. The company also provides dementia care, bariatric room solutions, prone positioning...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1957
• Employees: 7,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: A39

Financial Performance

In 2025, Arjo AB's revenue was 11.00 billion, a decrease of -2.59% compared to the previous year's 11.29 billion. Earnings were 334.00 million, a decrease of -32.93%.

Financial numbers in SEK